Stock Research for OVAS

OVAS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

OVAS Stock Chart & Research Data

The OVAS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OVAS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


OVAS Due diligence Resources & Stock Charts

The OVAS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OVAS Detailed Price Forecast - CNN Money CNN View OVAS Detailed Summary - Google Finance
Yahoo View OVAS Detailed Summary - Yahoo! Finance Zacks View OVAS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View OVAS Trends & Analysis - Trade-Ideas Barrons View OVAS Major Holders - Barrons
NASDAQ View OVAS Call Transcripts - NASDAQ Seeking View OVAS Breaking News & Analysis - Seeking Alpha
Spotlight View OVAS Annual Report - CompanySpotlight.com OTC Report View OVAS OTC Short Report - OTCShortReport.com
TradeKing View OVAS Fundamentals - TradeKing Charts View OVAS SEC Filings - Bar Chart
WSJ View Historical Prices for OVAS - The WSJ Morningstar View Performance/Total Return for OVAS - Morningstar
MarketWatch View the Analyst Estimates for OVAS - MarketWatch CNBC View the Earnings History for OVAS - CNBC
StockMarketWatch View the OVAS Earnings - StockMarketWatch MacroAxis View OVAS Buy or Sell Recommendations - MacroAxis
Bullish View the OVAS Bullish Patterns - American Bulls Short Pains View OVAS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View OVAS Stock Mentions - StockTwits PennyStocks View OVAS Stock Mentions - PennyStockTweets
Twitter View OVAS Stock Mentions - Twitter Invest Hub View OVAS Investment Forum News - Investor Hub
Yahoo View OVAS Stock Mentions - Yahoo! Message Board Seeking Alpha View OVAS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for OVAS - SECform4.com Insider Cow View Insider Transactions for OVAS - Insider Cow
CNBC View OVAS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OVAS - OTC Markets
Yahoo View Insider Transactions for OVAS - Yahoo! Finance NASDAQ View Institutional Holdings for OVAS - NASDAQ


Stock Charts

FinViz View OVAS Stock Insight & Charts - FinViz.com StockCharts View OVAS Investment Charts - StockCharts.com
BarChart View OVAS Stock Overview & Charts - BarChart Trading View View OVAS User Generated Charts - Trading View




Latest Financial News for OVAS


INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS
Posted on Friday November 16, 2018

NEW YORK , Nov. 16, 2018 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...


The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug
Posted on Friday November 02, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 1) Gritstone Oncology Inc (NASDAQ: GRTS ) Repligen Corporation ...


OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
Posted on Thursday November 01, 2018

OvaScienceSM (OVAS) and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, today announced that the companies have updated the terms of their merger agreement and increased the size of the associated financing, strengthening the position of the combined company. Great Point Partners has joined the previously-disclosed investor syndicate, which includes New Enterprise Associates, Frazier Healthcare Partners, and Roche Venture Fund, among others, bringing the total expected proceeds of the financing to approximately $50 million in the combined company, at the same valuation as the merger.


OvaScience: 2Q Earnings Snapshot
Posted on Thursday August 09, 2018

The Waltham, Massachusetts-based company said it had a loss of 22 cents per share. Losses, adjusted for restructuring costs, were 14 cents per share. The infertility treatment company posted revenue of ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.